Page last updated: 2024-08-21

2-piperidone and Brain Neoplasms

2-piperidone has been researched along with Brain Neoplasms in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (20.00)	18.2507
2000's	4 (40.00)	29.6817
2010's	4 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Botelho de Souza, LE; Brassesco, MS; de Oliveira, HF; Paiva, HH; Pezuk, JA; Roberto, GM; Tone, LG; Umezawa, K; Vieira, GM	1
Barboza, JN; da Nóbrega, FR; de Sousa, DP; Nascimento Sousa, SCS; Ozdemir, O; Turkez, H	1
Almeida, RN; Bezerra Filho, CDSM; Nóbrega, FRD; Ozdemir, O; Perez-Castillo, Y; Sousa, DP; Tejera, E; Turkez, H	1
Burzynski, GS; Burzynski, SR; Janicki, TJ; Marszalek, A	1
Burzynski, SR	1
Hammer, MR; Jonas, WB	1
Bestak, M; Burzynski, SR; Janicki, TJ; Jurida, GF; Khan, MI; Lewy, RI; Szymkowski, BG; Weaver, RA	1
Burzynski, SR; Dolgopolov, V; Janicki, T; Jurida, G; Khan, M; Szymkowski, B; Weaver, RA	1
Hara, H; Hirohata, M; Maruiwa, H; Shigemori, M; Sugita, Y; Tsuda, H	1
Ames, MM; Buckner, JC; Cascino, TL; Figg, WD; Lim, S; Malkin, MG; Reed, E; Reid, JM; Tong, WP	1

Reviews

1 review(s) available for 2-piperidone and Brain Neoplasms

Article	Year
The present state of antineoplaston research (1). Integrative cancer therapies, 2004, Volume: 3, Issue:1 Topics: Adenocarcinoma; Benzeneacetamides; Brain Neoplasms; Child; Clinical Trials as Topic; Colonic Neoplasms; Complementary Therapies; Gene Expression Profiling; Gene Expression Regulation; Genes, p53; Glioma; Humans; Piperidones; Survival Analysis	2004

Trials

3 trial(s) available for 2-piperidone and Brain Neoplasms

Article	Year
Phase II study of antineoplaston A10 and AS2-1 in children with recurrent and progressive multicentric glioma : a preliminary report. Drugs in R&D, 2004, Volume: 5, Issue:6 Topics: Adolescent; Antineoplastic Agents; Astrocytoma; Benzeneacetamides; Brain Neoplasms; Child; Child, Preschool; Disease Progression; Drug Combinations; Drug Therapy, Combination; Female; Glioma; Glutamine; Humans; Infant; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Phenylacetates; Piperidones; Survival Analysis; Treatment Outcome	2004
Long-term survival of high-risk pediatric patients with primitive neuroectodermal tumors treated with antineoplastons A10 and AS2-1. Integrative cancer therapies, 2005, Volume: 4, Issue:2 Topics: Antineoplastic Agents; Benzeneacetamides; Brain Neoplasms; Child, Preschool; Disease Progression; Drug Combinations; Drug Therapy, Combination; Female; Glutamine; Humans; Infant; Male; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive; Phenylacetates; Piperidones; Survival Analysis; Treatment Outcome	2005
Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma. Mayo Clinic proceedings, 1999, Volume: 74, Issue:2 Topics: Adult; Antineoplastic Agents; Astrocytoma; Benzeneacetamides; Brain Neoplasms; Confusion; Disorders of Excessive Somnolence; Drug Administration Schedule; Drug Combinations; Female; Glioblastoma; Glutamine; Humans; Injections, Intravenous; Male; Middle Aged; Patient Selection; Phenylacetates; Piperidones; Seizures; Severity of Illness Index; Treatment Outcome	1999

Other Studies

6 other study(ies) available for 2-piperidone and Brain Neoplasms

Article	Year
DTCM-glutarimide Delays Growth and Radiosensitizes Glioblastoma. Anti-cancer agents in medicinal chemistry, 2018, Volume: 18, Issue:9 Topics: Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Glioblastoma; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Piperidones; Radiation-Sensitizing Agents	2018
Piplartine Analogues and Cytotoxic Evaluation against Glioblastoma. Molecules (Basel, Switzerland), 2018, Jun-08, Volume: 23, Issue:6 Topics: Apoptosis; Biological Availability; Brain Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Piperidones; Plant Extracts	2018
NFBTA: A Potent Cytotoxic Agent against Glioblastoma. Molecules (Basel, Switzerland), 2019, Jun-29, Volume: 24, Issue:13 Topics: Acrylamides; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dioxolanes; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Molecular Docking Simulation; Piperidones	2019
Complete response and long-term survival (>20 years) of a child with tectal glioma: a case report. Pediatric neurosurgery, 2015, Volume: 50, Issue:2 Topics: Adolescent; Benzeneacetamides; Brain Neoplasms; Drug Combinations; Follow-Up Studies; Glioma; Glutamine; Humans; Male; Neoplasm Recurrence, Local; Phenylacetates; Piperidones; Treatment Outcome	2015
Managing social conflict in complementary and alternative medicine research: the case of antineoplastons. Integrative cancer therapies, 2004, Volume: 3, Issue:1 Topics: Benzeneacetamides; Brain Neoplasms; Clinical Trials, Phase II as Topic; Communication; Complementary Therapies; Conflict of Interest; Documentation; Drug Combinations; Glutamine; Humans; Interprofessional Relations; Phenylacetates; Physician's Role; Piperidones; Power, Psychological; Problem Solving; Social Conditions; Trust	2004
The effect of Antineoplaston, a new antitumor agent on malignant brain tumors. The Kurume medical journal, 1995, Volume: 42, Issue:3 Topics: Adult; Antineoplastic Agents; Astrocytoma; Benzeneacetamides; Brain Neoplasms; Child; Drug Combinations; Female; Glioblastoma; Glioma; Glutamine; Humans; Male; Medulloblastoma; Middle Aged; Phenylacetates; Piperidones	1995